NDC 72606-029 – Steqeyma

Ustekinumab 130 mg/26mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC72606-029

Product details

Brand name
Steqeyma
Generic name
Ustekinumab-stba
Labeler
CELLTRION USA, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
BLA · BLA761338
Marketed since
March 12, 2025
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Steqeyma →

Package NDC codes (1)

Package NDCDescriptionSince
72606-029-011 VIAL, SINGLE-USE in 1 CARTON (72606-029-01) / 26 mL in 1 VIAL, SINGLE-USEMar 12, 2025

Other Steqeyma products